Case File
efta-efta01519414DOJ Data Set 10CorrespondenceEFTA Document EFTA01519414
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01519414
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...
Extracted Text (OCR)
EFTA DisclosureText extracted via OCR from the original document. May contain errors from the scanning process.
CHISLAINE MAXWELL
ACCT.
For the Period 2/1/14 to 2/28/14
Equity Summary
Asset Categories
Beginning
Markel Value
Ending
Market Value
Change
In Value
Current
Allocation
US Large Cap Equity
495228.99
489,061.56
(6.147.43)
9%
US Small/Mid Cap Equity
15,060.00
14,265.00
(795.00)
1%
Non•US Equity
159.92
172.57
1265
1%
Preferred Stocks
440,937.00
445,348 00
4 411 00
8%
Concentrated & Other Equity
165.640 50
167.266 50
1,626 00
3%
Total Value
51,117,026.41
51,116,133.63
($892.78)
22%
Market Value/Cost
Current
Period Value
Markel Value
1,116,133.63
Tax Cost
1,034,682.24
Unrealized Gain/Loss
81,45139
Estimated Annual Income
50,062.72
Accrued Dividends
4,028.00
Yield
4.47%
J.P.Morgan
Asset Categories
US Large Cap Equity
Preferred SIOCAS
Equity as a percentage of your portfolio 22 %
Account
Page 5 o' 28
Consolidated Statement Page 8
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL
JPM-SDNY-00046700
SDNY_GM_00315898
EFTA01519414
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.